"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see if campath-1H can be used in first time renal transplant
subjects to prevent rejection and reduce the overall amount of anti-rejection medications
that patients take on a daily basis.